Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Tracon Pharmaceuticals, Inc. | a15-6490_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 10, 2015
TRACON Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware |
|
001-36818 |
|
34-2037594 |
|
|
|
|
|
|
|
(State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
of incorporation) |
|
|
|
|
|
8910 University Center Lane, Suite 700 |
|
92122 |
|
|
|
|
|
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (858) 550-0780
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On March 10, 2015, TRACON Pharmaceuticals, Inc. (“TRACON”) issued a press release announcing its financial results for the year ended December 31, 2014. A copy of this press release is furnished as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
99.1 |
Press release issued by TRACON Pharmaceuticals, Inc. on March 10, 2015 announcing its financial results for the year ended December 31, 2014. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
TRACON Pharmaceuticals, Inc. | |
|
|
|
|
|
|
|
|
|
|
|
Dated: March 10, 2015 |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Charles P. Theuer |
|
|
|
|
Charles P. Theuer, M.D., Ph.D. |
|
|
|
|
President and Chief Executive Officer |
EXHIBIT INDEX
|
Exhibit |
|
Description |
|
|
|
|
|
99.1 |
|
Press release issued by TRACON Pharmaceuticals, Inc. on March 10, 2015 announcing its financial results for the year ended December 31, 2014. |